Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB-Reference-Cited by-同舟云学术

Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB

Published:2016-08-10 Issue:8 Volume:11 Page:e0160062
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Shenai Shubhada,Ronacher Katharina,Malherbe Stefanus,Stanley Kim,Kriel Magdalena,Winter Jill,Peppard Thomas,Barry Charles E.,Wang Jing,Dodd Lori E.,Via Laura E.,Barry Clifton E.,Walzl Gerhard,Alland David

Funder

Catalysis Foundation for Health

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference25 articles.

1. Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis;WJ Su;The European respiratory journal,2011

2. Baseline sputum time to detection predicts month two culture conversion and relapse in non-HIV-infected patients;AC Hesseling;The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease,2010

3. Month 2 culture status and treatment duration as predictors of recurrence in pulmonary tuberculosis: model validation and update;RS Wallis;PloS one,2015

4. Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies;EV Kurbatova;The Lancet Respiratory medicine,2015

5. Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis;DJ Horne;The Lancet infectious diseases,2010

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developing biomarker assays to accelerate tuberculosis drug development: defining target product profiles;The Lancet Microbe;2024-09

2. Artificial intelligence-based radiographic extent analysis to predict tuberculosis treatment outcomes: a multicenter cohort study;Scientific Reports;2024-06-07

3. Tuberculosis treatment monitoring tests during routine practice: study design guidance;Clinical Microbiology and Infection;2024-04

4. A Bedaquiline, Pyrazinamide, Levofloxacin, Linezolid, and Clofazimine Second-line Regimen for Tuberculosis Displays Similar Early Bactericidal Activity as the Standard Rifampin-Based First-line Regimen;The Journal of Infectious Diseases;2023-12-07

5. Early Microbiologic Markers of Pulmonary Tuberculosis Treatment Outcomes;Annals of the American Thoracic Society;2023-12